全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1523530-29-1 | N-[(3R,4R)-3-Fluoro-4-piperidinyl]carbamic acid 1,1-dimethylethyl ester | C10H19FN2O2 |
| 1523530-36-0 | cis-4-Amino-1-boc-3-hydroxypiperidine | C10H20N2O3 |
| 1523530-42-8 | (1R,3R)-3-Aminocyclopentanol hydrochloride (1:1) | C5H11NO.HCl |
| 1523541-74-3 | (1R,3R)-3-Aminocyclopentanol hydrochloride (1:1) | C5H11NO.HCl |
| 1523541-82-3 | (2R,4R)-4-fluoropyrrolidine-2-carboxylic acid hydrochloride | C5H9ClFNO2 |
| 1523571-08-5 | tert-Butyl 2,6-diazaspiro[3.5]nonane-2-carboxylate hemioxalate | 2(C12H22N2O2).C2H2O4 |
| 1523571-10-9 | 1,6-Diazaspiro[3.3]heptane-1-carboxylic acid 1,1-dimethylethyl ester ethanedioate (2:1) | 2(C10H18N2O2).C2H2O4 |
| 1523571-19-8 | 1-(3-Oxetanyl)piperazine ethanedioate (2:1) | 2(C7H14N2O).C2H2O4 |
| 1523572-06-6 | N1,N3-Dimethylbicyclo[1.1.1]pentane-1,3-diamine hydrochloride (1:2) | C7H14N2.2(HCl) |
| 1523618-12-3 | 3,3-Difluoropiperidin-4-one hydrochloride | C5H8ClF2NO |
| 1527473-33-1 | 3-[4-(4-Morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile;PF 06447475 | C17H15N5O |
| 1527475-61-1 | 1-methyl-4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)pyrrole-2-carbonitrile;PFE-360 | C16H16N6O |
| 1527479-23-7 | [4-(Adamantan-1-yl)phenyl]boronic acid | C16H21BO2 |
| 1528636-39-6 | Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-alpha-D-xylo-hexopyranoside | C23H29ClO8 |
| 1529613-64-6 | 3-Amino-4-bromo-2,6-difluorobenzoic acid methyl ester | C8H6BrF2NO2 |
| 1529795-01-4 | 5-Bromo-4-iodo-3-pyridinecarboxylic acid methyl ester | C7H5BrINO2 |
| 1530308-87-2 | 2-(3-Cyano-4-propoxyphenyl)-4-methyl-5-thiazolecarboxylic acid | C15H14N2O3S |
| 1531634-31-7 | 2-[[(6-Methyl-2-pyridinyl)amino]carbonyl]-5-(trifluoromethyl)benzoic acid | C15H11F3N2O3 |
| 1532533-67-7 | 2-[(1S)-1-[4-Amino-3-[3-fluoro-4-(1-methylethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)-4H-1-benzopyran-4-one;RP 5264; TGR 1202 | C31H24F3N5O3 |
| 1533406-38-0 | 9-[1,1'-Biphenyl]-3-yl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole | C30H28BNO2 |
| 1533426-72-0 | 2,3-Dihydro-5,6-bis[(E)-(phenylmethylene)amino]-2-thioxo-4(1H)-pyrimidinone | C18H14N4OS |
| 1533519-84-4 | 4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazole-3-thiol | C15H13N3S |
| 1533519-85-5 | Methyl 2-[[4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetate | C18H17N3O2S |
| 1533519-92-4 | 4-Cyclopropyl-1-naphthalenamine hydrochloride (1:1) | C13H13N.HCl |
| 1533932-57-8 | 3-Bromo-5-fluoro-4-methylbenzoic acid methyl ester | C9H8BrFO2 |
| 1535210-94-6 | 3-Chloro-2-(1,1-difluoro-2-propen-1-yl)-6-methoxyquinoxaline | C12H9ClF2N2O |
| 1536200-31-3 | rel-N2-[5-Chloro-1-[(3R,4R)-3-fluoro-1-(3-oxetanyl)-4-piperidinyl]-1H-pyrazol-4-yl]-N4-methyl-5-(trifluoromethyl)-2,4-pyrimidinediamine;GNE-9605 | C17H20ClF4N7O |
| 1536473-72-9 | [2'-(amino-κN)[1,1'-biphenyl]-2-yl-κC][[3,6-dimethoxy-2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]bis(1,1-dimethylethyl)phosphine-κP](methanesulfonato-κO)-Palladium;tBuBrettPhos Pd G3 | C44H62NO5PPdS |
| 1536988-56-3 | 4,4-Difluoro-2,2-dimethylbutanoic acid | C6H10F2O2 |
| 1537465-19-2 | 1-(4-Piperidinyl)-3-azetidinol hydrochloride (1:2) | C8H16N2O.2(HCl) |
| 1537889-07-8 | JWH-122 4-Hydroxypentyl | C25H25NO2 |
| 1538235-22-1 | 3-Bromo-6-fluoro-2-hydroxybenzoic acid | C7H4BrFO3 |
| 1538604-68-0 | N-[2-[[6-(2,6-Dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl]amino]-3-methylphenyl]-2-propenamide | C26H22Cl2N4O3 |
| 1538772-53-0 | 1-(3-Fluoropropyl)azetidin-3-amine | C6H13FN2 |
| 1539266-39-1 | 4-Ethyl-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]benzeneethanamine Hydrochloride | C20H28ClNO3 |
| 1539314-06-1 | (R)-1-[1-(Methylsulfonyl)propan-2-yl]-4-(trifluoromethyl)-1H-indole-5-carbonitrile | C14H13F3N2O2S |
| 1541171-67-8 | Carfilzomib Impurity 52;N-{(2S)-2-[(4-Morpholinylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-[(4S)-1-chloro-2-hydroxy-2,6-dimethyl-3-oxo-4-heptanyl]-L-phenylalaninamide | C40H58ClN5O7 |
| 1541172-75-1 | Carfilzomib Impurity 2;(2S)-N-[(2S)-1-[[(2R,4S)-1,2-dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide | C40H59N5O8 |
| 1542268-31-4 | (3R,5R)-3,5-Dimethylmorpholine Hydrochloride | C6H13NO.HCl |
| 1542705-92-9 | 1-[7,8-Dihydro-4-[(phenylmethyl)amino]-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indole-4-carboxamide;CB 5083 | C24H23N5O2 |
| 1542938-62-4 | 4-Cyano-1-methyl-4-piperidinecarboxylic acid | C8H12N2O2 |
| 1543789-74-7 | 1-((Benzyloxy)carbonyl)-5,5-difluoropiperidine-2-carboxylic acid | C14H15F2NO4 |
| 1544673-46-2 | (2-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)Methanol | C14H21BO3 |
| 1545469-02-0 | Carfilzomib Impurity 5 TFA Salt;(S)-2-((S)-2-amino-4-phenylbutanamido)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)pentanamide, 2,2,2-trifluoroacetate (1:1) | C34H48N4O5 .C2HF3O2 |
| 1547491-70-2 | 3-Bromo-9,9-diphenyl-9H-fluorene | C25H17Br |
| 1547492-13-6 | 9-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole | C24H24BNO2 |
| 1548450-59-4 | 4-Bromo-9-methyl-9-phenyl-9H-fluorene | C20H15Br |
| 1548581-40-3 | 9-([1,1':3',1''-Terphenyl]-4-yl)-9'-phenyl-9H,9'H-3,3'-bicarbazole;3-(9-phenylcarbazol-3-yl)-9-[4-(3-phenylphenyl)phenyl]carbazole | C48H32N2 |
| 1548743-66-3 | 8-[(1S)-1-[8-(Trifluoromethyl)-7-[[cis-4-(trifluoromethyl)cyclohexyl]oxy]-2-naphthalenyl]ethyl]-8-azabicyclo[3.2.1]octane-3-carboxylic acid | C28H31F6NO3 |
| 1550008-55-3 | (2E)-3-(3-Chlorophenyl)-N-[2-[methyl(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)amino]-2-oxoethyl]-2-propenamide | C17H21ClN2O4S |